Vimarsana
Biggest News Aggregation in the World

Page 2 - Weak Sales News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Weak Sales. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Weak Sales Today - Breaking & Trending Today

Tesla's China Sales Drop 11% in September; BYD Sees 42.8% Surge - Vimarsana News

Tesla's China Sales Drop 11% in September; BYD Sees 42.8% Surge

EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.

FTSE Closes Flat Amid Geopolitical Uncertainty Around Israel-Hamas Conflict - Vimarsana News

FTSE Closes Flat Amid Geopolitical Uncertainty Around Israel-Hamas Conflict

London's blue-chip index finished Monday's trading session roughly flat, edging down 0.03% at 7492.21 points. A sharp rise in energy prices, along with concerns over an escalation outside the...

Beyonce's Ivy Park Line Revenue Reportedly Drops More Than 50 Percent in 2022 - Vimarsana News

Beyonce's Ivy Park Line Revenue Reportedly Drops More Than 50 Percent in 2022

The athleisure clothing line launched in collaboration between Adidas and the 'Cuff It' singer reportedly leaves a '$200 million hole in the company's annual projections' as a result of 'weak sales.'

Dr Reddy's is now No.2 drug firm as old order changes - Vimarsana News

Dr Reddy's is now No.2 drug firm as old order changes

Aurobindo is bogged down by weak sales and price decline for its current formulation biz in US, which accounted for 46% of total sales

Broker's call: Colgate Palmolive (Neutral) - The Hindu BusinessLine - Vimarsana News

Broker's call: Colgate Palmolive (Neutral) - The Hindu BusinessLine

Broker's call: Colgate Palmolive (Neutral) | Updated on CMP: ₹1579 Colgate Palmolive’s weak sales growth trend has persisted in recent quarters – the two-year average sales growth is in the 5–6 per cent range. It has now been six years since the company reported over 7 per cent sales growth for any year. The cornerstones of our earlier optimism on improved topline growth were: new launches in oral care; a potentially higher play in naturals (38– 39 per cent of the category where Colgate was significantly under-indexed); and new launches in Non-Oral Care (only 2 per cent of sales cur...